Canopy Growth (CGC) Cash from Investing Activities (2019 - 2025)
Canopy Growth's (CGC) quarterly Cash from Investing Activities came in at $3.8 million in Q4 2025, up 118.72% year-on-year from $1.7 million in Q4 2024, and down 68.9% quarter-over-quarter from $12.2 million in Q3 2025.
Canopy Growth (CGC) Cash from Investing Activities (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Cash from Investing Activities across 7 years of filings, most recently posting $3.8 million for Q4 2025.
- Cash from Investing Activities for Q4 2025 came in at $3.8 million, up 118.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $24.1 million (up 178.73% YoY), and the FY2025 annual result was -$33.3 million, down 120.44% from the prior year.
- Cash from Investing Activities came in at $3.8 million for Q4 2025 at Canopy Growth, down from $12.2 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $260.8 million in Q3 2021 to a low of -$438.7 million in Q1 2021.
- The 5-year median for Cash from Investing Activities is $8.4 million (2024), against an average of $11.1 million.
- Across the five-year window, Cash from Investing Activities slumped 788.29% in 2021 and soared 695.51% in 2022, its largest moves.
- Canopy Growth's Cash from Investing Activities stood at -$19.7 million in 2021, then surged by 695.51% to $117.2 million in 2022, then tumbled by 111.11% to -$13.0 million in 2023, then slumped by 55.02% to -$20.2 million in 2024, then surged by 118.72% to $3.8 million in 2025.
- The last three Cash from Investing Activities figures came in at $3.8 million (Q4 2025), $12.2 million (Q3 2025), and -$508807.3 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | Canopy Growth | 11.27 Mn | -137.42 Mn | 15.39 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.78 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 12.16 Mn |
| Sep 30, 2025 | 12.16 Mn |
| Jun 30, 2025 | -508,807.31 |
| Jun 30, 2025 | -508,807.31 |
| Mar 31, 2025 | 8.65 Mn |
| Mar 31, 2025 | 8.65 Mn |
| Dec 31, 2024 | -20.19 Mn |
| Dec 31, 2024 | -20.19 Mn |
| Sep 30, 2024 | 8.21 Mn |
| Sep 30, 2024 | 8.21 Mn |
| Jun 30, 2024 | -31.58 Mn |
| Jun 30, 2024 | -31.58 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | -13.03 Mn |
| Dec 31, 2023 | -13.03 Mn |
| Sep 30, 2023 | 57.78 Mn |
| Sep 30, 2023 | 57.78 Mn |